APO RESEARCH · REPORT
Veterinary Insulin Syringes
Veterinary insulin syringes provide concentration-specific graduations and a small-volume delivery configuration for insulin products used in veterinary applications.

Product & engineering
Understand the product.
Veterinary labelling does not make different unit scales interchangeable. The specified concentration, graduations and needle configuration remain separate requirements.
What turns activity into demand
Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.
The commercial boundary
Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.
Which concentration does the graduation scale assume?
Veterinary labelling does not make different unit scales interchangeable. The specified concentration, graduations and needle configuration remain separate requirements.
Selected research
Industry Growth & Trends
Global Veterinary Insulin Syringes Industry Growth and Trends Forecast to 2032
Market perspective
The global Veterinary Insulin Syringes market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Veterinary Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Veterinary Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Veterinary Insulin Syringes include B. Braun VetCare, BD, Cardinal Health, CarePoint VET, Covetrus, Knight Benedikt, MWI Veterinary Supply, Pharma Supply and SOL-Millennium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Veterinary Insulin Syringes market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Veterinary Insulin Syringes market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Insulin Syringes market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Insulin Syringes.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Insulin Syringes market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Veterinary Insulin Syringes Market by Company
B. Braun VetCare
BD
Cardinal Health
CarePoint VET
Covetrus
Knight Benedikt
MWI Veterinary Supply
Pharma Supply
SOL-Millennium
Trividia Health
UltiMed
Medtronic
Merck
Veterinary Insulin Syringes Segment by Type
U-40
U-100
Veterinary Insulin Syringes Segment by Application
Companion Animals
Livestock Animals
Veterinary Insulin Syringes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Insulin Syringes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Insulin Syringes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Insulin Syringes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Insulin Syringes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Veterinary Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- U-40
- U-100
Applications
- Companion Animals
- Livestock Animals
Companies covered
- B. Braun VetCare
- BD
- Cardinal Health
- CarePoint VET
- Covetrus
- Knight Benedikt
- MWI Veterinary Supply
- Pharma Supply
- SOL-Millennium
- Trividia Health
- UltiMed
- Medtronic
- Merck
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Veterinary Insulin Syringes Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Veterinary Insulin Syringes Sales Estimates and Forecasts (2021-2032)
- 1.3 Veterinary Insulin Syringes Market by Type
- 1.3.1 U-40
- 1.3.2 U-100
- 1.4 Global Veterinary Insulin Syringes Market Size by Type
- 1.4.1 Global Veterinary Insulin Syringes Market Size Overview by Type (2021-2032)
- 1.4.2 Global Veterinary Insulin Syringes Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Veterinary Insulin Syringes Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Veterinary Insulin Syringes Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Veterinary Insulin Syringes Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Veterinary Insulin Syringes Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Veterinary Insulin Syringes Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Veterinary Insulin Syringes Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Veterinary Insulin Syringes Industry Trends
- 2.2 Veterinary Insulin Syringes Industry Drivers
- 2.3 Veterinary Insulin Syringes Industry Opportunities and Challenges
- 2.4 Veterinary Insulin Syringes Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Veterinary Insulin Syringes Revenue (2021-2026)
- 3.2 Global Top Players by Veterinary Insulin Syringes Sales (2021-2026)
- 3.3 Global Top Players by Veterinary Insulin Syringes Price (2021-2026)
- 3.4 Global Veterinary Insulin Syringes Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Veterinary Insulin Syringes Major Company Production Sites & Headquarters
- 3.6 Global Veterinary Insulin Syringes Company, Product Type & Application
- 3.7 Global Veterinary Insulin Syringes Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Veterinary Insulin Syringes Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Veterinary Insulin Syringes Players Market Share by Revenue in 2025
- 3.8.3 2025 Veterinary Insulin Syringes Tier 1, Tier 2, and Tier 3
4 Veterinary Insulin Syringes Regional Status and Outlook
- 4.1 Global Veterinary Insulin Syringes Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Veterinary Insulin Syringes Historic Market Size by Region
- 4.2.1 Global Veterinary Insulin Syringes Sales in Volume by Region (2021-2026)
- 4.2.2 Global Veterinary Insulin Syringes Sales in Value by Region (2021-2026)
- 4.2.3 Global Veterinary Insulin Syringes Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Veterinary Insulin Syringes Forecasted Market Size by Region
- 4.3.1 Global Veterinary Insulin Syringes Sales in Volume by Region (2027-2032)
- 4.3.2 Global Veterinary Insulin Syringes Sales in Value by Region (2027-2032)
- 4.3.3 Global Veterinary Insulin Syringes Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Insulin Syringes by Application
- 5.1 Veterinary Insulin Syringes Market by Application
- 5.1.1 Companion Animals
- 5.1.2 Livestock Animals
- 5.2 Global Veterinary Insulin Syringes Market Size by Application
- 5.2.1 Global Veterinary Insulin Syringes Market Size Overview by Application (2021-2032)
- 5.2.2 Global Veterinary Insulin Syringes Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Veterinary Insulin Syringes Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Veterinary Insulin Syringes Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Veterinary Insulin Syringes Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Veterinary Insulin Syringes Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Veterinary Insulin Syringes Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Veterinary Insulin Syringes Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 B. Braun VetCare
- 6.1.1 B. Braun VetCare Company Information
- 6.1.2 B. Braun VetCare Business Overview
- 6.1.3 B. Braun VetCare Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 B. Braun VetCare Veterinary Insulin Syringes Product Portfolio
- 6.1.5 B. Braun VetCare Recent Developments
- 6.2 BD
- 6.2.1 BD Company Information
- 6.2.2 BD Business Overview
- 6.2.3 BD Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 BD Veterinary Insulin Syringes Product Portfolio
- 6.2.5 BD Recent Developments
- 6.3 Cardinal Health
- 6.3.1 Cardinal Health Company Information
- 6.3.2 Cardinal Health Business Overview
- 6.3.3 Cardinal Health Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Cardinal Health Veterinary Insulin Syringes Product Portfolio
- 6.3.5 Cardinal Health Recent Developments
- 6.4 CarePoint VET
- 6.4.1 CarePoint VET Company Information
- 6.4.2 CarePoint VET Business Overview
- 6.4.3 CarePoint VET Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 CarePoint VET Veterinary Insulin Syringes Product Portfolio
- 6.4.5 CarePoint VET Recent Developments
- 6.5 Covetrus
- 6.5.1 Covetrus Company Information
- 6.5.2 Covetrus Business Overview
- 6.5.3 Covetrus Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Covetrus Veterinary Insulin Syringes Product Portfolio
- 6.5.5 Covetrus Recent Developments
- 6.6 Knight Benedikt
- 6.6.1 Knight Benedikt Company Information
- 6.6.2 Knight Benedikt Business Overview
- 6.6.3 Knight Benedikt Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Knight Benedikt Veterinary Insulin Syringes Product Portfolio
- 6.6.5 Knight Benedikt Recent Developments
- 6.7 MWI Veterinary Supply
- 6.7.1 MWI Veterinary Supply Company Information
- 6.7.2 MWI Veterinary Supply Business Overview
- 6.7.3 MWI Veterinary Supply Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 MWI Veterinary Supply Veterinary Insulin Syringes Product Portfolio
- 6.7.5 MWI Veterinary Supply Recent Developments
- 6.8 Pharma Supply
- 6.8.1 Pharma Supply Company Information
- 6.8.2 Pharma Supply Business Overview
- 6.8.3 Pharma Supply Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Pharma Supply Veterinary Insulin Syringes Product Portfolio
- 6.8.5 Pharma Supply Recent Developments
- 6.9 SOL-Millennium
- 6.9.1 SOL-Millennium Company Information
- 6.9.2 SOL-Millennium Business Overview
- 6.9.3 SOL-Millennium Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 SOL-Millennium Veterinary Insulin Syringes Product Portfolio
- 6.9.5 SOL-Millennium Recent Developments
- 6.10 Trividia Health
- 6.10.1 Trividia Health Company Information
- 6.10.2 Trividia Health Business Overview
- 6.10.3 Trividia Health Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Trividia Health Veterinary Insulin Syringes Product Portfolio
- 6.10.5 Trividia Health Recent Developments
- 6.11 UltiMed
- 6.11.1 UltiMed Company Information
- 6.11.2 UltiMed Business Overview
- 6.11.3 UltiMed Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 UltiMed Veterinary Insulin Syringes Product Portfolio
- 6.11.5 UltiMed Recent Developments
- 6.12 Medtronic
- 6.12.1 Medtronic Company Information
- 6.12.2 Medtronic Business Overview
- 6.12.3 Medtronic Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Medtronic Veterinary Insulin Syringes Product Portfolio
- 6.12.5 Medtronic Recent Developments
- 6.13 Merck
- 6.13.1 Merck Company Information
- 6.13.2 Merck Business Overview
- 6.13.3 Merck Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Merck Veterinary Insulin Syringes Product Portfolio
- 6.13.5 Merck Recent Developments
7 North America by Country
- 7.1 North America Veterinary Insulin Syringes Sales by Country
- 7.1.1 North America Veterinary Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Veterinary Insulin Syringes Sales by Country (2021-2026)
- 7.1.3 North America Veterinary Insulin Syringes Sales Forecast by Country (2027-2032)
- 7.2 North America Veterinary Insulin Syringes Market Size by Country
- 7.2.1 North America Veterinary Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Veterinary Insulin Syringes Market Size by Country (2021-2026)
- 7.2.3 North America Veterinary Insulin Syringes Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Veterinary Insulin Syringes Sales by Country
- 8.1.1 Europe Veterinary Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Veterinary Insulin Syringes Sales by Country (2021-2026)
- 8.1.3 Europe Veterinary Insulin Syringes Sales Forecast by Country (2027-2032)
- 8.2 Europe Veterinary Insulin Syringes Market Size by Country
- 8.2.1 Europe Veterinary Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Veterinary Insulin Syringes Market Size by Country (2021-2026)
- 8.2.3 Europe Veterinary Insulin Syringes Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Veterinary Insulin Syringes Sales by Country
- 9.1.1 Asia-Pacific Veterinary Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Veterinary Insulin Syringes Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Veterinary Insulin Syringes Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Veterinary Insulin Syringes Market Size by Country
- 9.2.1 Asia-Pacific Veterinary Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Veterinary Insulin Syringes Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Veterinary Insulin Syringes Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Veterinary Insulin Syringes Sales by Country
- 10.1.1 South America Veterinary Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Veterinary Insulin Syringes Sales by Country (2021-2026)
- 10.1.3 South America Veterinary Insulin Syringes Sales Forecast by Country (2027-2032)
- 10.2 South America Veterinary Insulin Syringes Market Size by Country
- 10.2.1 South America Veterinary Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Veterinary Insulin Syringes Market Size by Country (2021-2026)
- 10.2.3 South America Veterinary Insulin Syringes Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Veterinary Insulin Syringes Sales by Country
- 11.1.1 Middle East and Africa Veterinary Insulin Syringes Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Veterinary Insulin Syringes Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Veterinary Insulin Syringes Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Veterinary Insulin Syringes Market Size by Country
- 11.2.1 Middle East and Africa Veterinary Insulin Syringes Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Veterinary Insulin Syringes Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Veterinary Insulin Syringes Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Veterinary Insulin Syringes Value Chain Analysis
- 12.1.1 Veterinary Insulin Syringes Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Veterinary Insulin Syringes Production Mode & Process
- 12.2 Veterinary Insulin Syringes Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Veterinary Insulin Syringes Distributors
- 12.2.3 Veterinary Insulin Syringes Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst